Industry responds to pharmaceutical study comparing a low-dose statin medication to dietary supplements
Benefits from a recent study1 funded by AstraZeneca, identified as the “Supplements, Placebo, or Rosuvastatin (Activity)” Research, when compared the results of its prescription small-dose statin (Rosuvastatin) to placebo and…